Company Filing History:
Years Active: 1992
Title: The Innovative Contributions of Janela McClure
Introduction
Janela McClure is a notable inventor based in the City of Vashon Island, Washington. She has made significant contributions to the field of medical research, particularly in the area of HIV diagnosis and treatment. Her work has the potential to impact countless lives through advancements in healthcare.
Latest Patents
Janela McClure holds a patent for "Monoclonal antibodies and peptides useful in treating and diagnosing HIV." This patent outlines methods and compositions for diagnosing and treating HIV using monoclonal antibodies that react with specific neutralizing regions of HIV proteins. The patent also includes the use of peptides or homologs from these regions and related nucleic acid segments. Notably, the exemplary neutralizing regions include selected portions of the env and gag genes from various HIV isolates. The patent details several monoclonal antibody secreting cell lines, including HIV-gp110-1 through -6 and HIV-p25-2 through -7, with their respective A.T.C.C. Accession Numbers.
Career Highlights
Janela McClure is currently employed at Bristol-Myers Squibb Company, where she continues her research and development efforts. Her work at this prestigious company allows her to collaborate with other talented professionals in the field.
Collaborations
Some of her notable coworkers include Mary K Shriver and Larry H Gosting. Their collaborative efforts contribute to the innovative research being conducted at Bristol-Myers Squibb Company.
Conclusion
Janela McClure's contributions to the field of HIV research through her patent and work at Bristol-Myers Squibb Company highlight her dedication to advancing medical science. Her innovative approach has the potential to lead to significant improvements in the diagnosis and treatment of HIV.